1. Food and Drug Administration. (2009) Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labeling claims. Washington, DC: Department of Health and Human Services.
http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf
. Accessed May 26, 2014.
2. Reeve, B. B., Wyrwich, K. W., Wu, A. W., Velikova, G., Terwee, C. B., Snyder, C. F., et al. (2013). ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Quality of Life Research,
22(8), 1889–1905.
3. Zbrozek, A., Hebert, J., Gogates, G., Thorell, R., Dell, C., Molsen, E., et al. (2013). Validation of electronic systems to collect patient-reported outcome (PRO) data-recommendations for clinical trial teams: Report of the ISPOR ePRO systems validation good research practices task force. Value Health,
16(4), 480–489.
4. Bingham III, C. O., Auger, C., Feldman, D., Noonan, V., Wolfe, D., Ahmed, S., & Bartlett, S. J. (2016). From research to care: Clinical applications of patient reported outcomes. Journal of Clinical Epidemiology
(in press).
5. Patient Centered Outcomes Research Institute: PCORI’s definition of “Patient-Centered Outcomes Research”.
http://www.pcori.org/content/patient-centered-outcomes-research
. Accessed September 14, 2015.